Prevalence of jejunal involvement in CD
What is the prevalence of jejunal involvement in patients with CD
What is known
- In a meta-analysis of 26 studies (>10,000 patients), among UGI-CD patients jejunal involvement was 36% and proximal ileal 32%, behind stomach (56%) and duodenum (55%). 1
- Pooled UGI-CD prevalence was 13% overall and 23% when limited to systematic endoscopic screening, indicating much detected disease is subclinical. 1
- In an Asian cohort of 483 CD patients, 38.3% carried an L4 phenotype at presentation, though this figure aggregates EGD, jejunal, and proximal ileal subtypes rather than isolating jejunal disease. 2
What is unknown / caveats
- Reported UGI-CD prevalence varies widely (12–80%) across retrospective series depending on screening intensity and diagnostic method
- No retrieved chunk reports isolated jejunal prevalence as a fraction of the entire CD population. The 36% is a proportion within UGI/L4-CD
- L4 is a heterogeneous single Montreal category grouping EGD, jejunal, and proximal ileal disease, so definitions vary between studies
- Prevalence is method-dependent. Capsule endoscopy/MRE reclassified up to 64% of patients in one study
- The population-wide prevalence of jejunal CD is not directly reported in the retrieved evidence and is confounded by variable screening and phenotyping.
References
- Lusetti F, Bezzio C, De Bernardi A, Puricelli M, Manes G, Saibeni S. Upper Gastrointestinal Crohn's Disease: Shedding Light on the Obscure L4 Classification Meaning. J Clin Med. 2025. PMID: 41303293.
- Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, Li XH, Feng R, He Y, Li ZP, Zeng ZR, Eliakim R, Ben-Horin S, Chen MH. Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?. Ther Adv Gastroenterol. 2018. PMID: 29899757.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
Sources retrieved: PMID 29899757 · PMID 41303293 · PMID 36639398 · PMID 30891327 · PMID 9590412 · PMID 9463587 · PMID 23546557 · PMID 15060461 · PMID 40218181 · PMID 41556938 · PMID 29991893
answered 2026-08-04 · corpus build b71369a6 · faithfulness 0.8888888888888888
Reviewer notes